Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways

FASEB Journal

Volumn 11, Issue 2, 1997, Pages 125-132

  Mundlos, S ^a,b   Olsen, B R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

bone; chondrodysplasia; growth plate; mutation

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

BONE DEVELOPMENT; BONE DISEASE; CARTILAGE CELL; CELL PROLIFERATION; DWARFISM; GROWTH PLATE; HUMAN; MESENCHYME; MUTATION; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKULL SUTURE;

EID: 0031035441     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.2.9039954     Document Type: Review

References (60)

1. Spranger, J. (1992) International classification of osteochondrodysplasias. Eur. J. Ped. 151, 407-415
2. Erlebacher, A., Filvaroff, E. H., Gitelman, S. E., and Derynck, R. (1995) Toward a molecular understanding of skeletal development. Cell 80, 371-378
3. Devlin, C. J., Brickell, P. M., Taylor, K. R., Hornbruch, A., Craig, R. K., and Wolpert, L. (1988) In situ hybridization reveals differential spatial distribution of mRNAs for type I and type II collagen in the chick limb bud. Development 103, 111-118
4. Mundlos, S. (1994) Expression patterns of matrix genes during human skeletal development. Progr. Histochem. Cytochem. 28, No. 3
5. Krumlauf, R. (1994) Hox genes in vertebrate development. Cell 78, 191-201
6. Morgan, B. A., Izpisua-Belmonte, J. C., Duboule, D., and Tabin, C. J. (1992) Targeted misexpression of Hox-4.6 in the avian limb bud causes apparent homeotic transformations. Nature (London) 358, 236-239
7. Rijii, F. M., Mark, M., Lakkaraju, S., Dierich, A., Dolle, P., and Chambon, P. (1993) A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene. Cell 75, 1333-1349
8. Muragaki, Y., Mundlos, S., Upton, J., and Olsen, B. R. (1996) Altered growth and branching pattern in synpolydactyly caused by mutations in HOXD13. Science 272, 548-551
9. Dolle, P., Dierich, A., LeMeur, M., Schimmang, T., Schukbaur, B., Chambon, P., and Duboule, D. (1993) Disruption of the Hoxd-13 gene induces localized heterochrony leading to mice with neotenic limbs. Cell 75, 431-441
10. Gruss, P., and Walther, C. (1992) Pax in development. Cell 69, 719-722
11. Balling, R., Deutsch, U., and Gruss, P. (1988) Undulated, a mutation affecting the development of the mouse skeleton, has a point mutation in the paired box of Pax 1. Cell 55, 531-535
12. Tassabehi, M., Read, A. P., Newton, V. E., Harris, R., Balling, R., Gruss, P., and Strachan, T. (1992) Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature (London) 355, 635-636
13. 2b), a mutation affecting development of the mouse neural-tube, shows a deletion within the paired homeodomain. Cell 67, 767-774
14. Zlotogora, J., Lerer, I., Bar-David, S., Ergaz, Z., and Abeliovich, D. (1995) Homozygosity for Waardenburg syndrome. Am. J. Human Genet. 56, 1173-1178
15. Vortkamp, A., Gessler, M., and Grzeschik, K.-H. (1991) GLI3 zinc-finger gene interrupted by translocations in Greig syndrome families. Nature (London) 352, 539-540
16. Hui, C. C., and Joyner, A. L. (1993) A mouse model of Greig cephalopolysyndactyly syndrome: the extra-toes* J mutation contains an intragenic deletion of the Gli3 gene. Nature Genet. 3, 241-246
17. Urist, M. R. (1965) Bone; formation and autoinduction. Science 150, 893-899
18. Kingsley, D. M. (1994) What do BMPs do in mammals? Clues from the mouse short-ear mutation. Trends Genet. 10, 16-21
19. Kingsley, D. M., Bland, A. E., Grubber, J. M., Marker, P. C., Russell, L. B., Copeland, N. C., and Jenkins, N. A. (1992) The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGFβ superfamily. Cell 71, 399-410
20. Storm, E. E., Huynh, T. V., Copeland, N. G., Jenkins, N. A., Kingsley, D. M., and Lee, S. J. (1994) Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature (London) 368, 639-643
21. Thomas, J. T., Lin, K., Nandedkar, M., Camargo, M., Cervenka, J., and Luyten, F. P. (1996) A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nature Genet. 12, 315-317
22. Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F. D., Keutel, J., Hustert, E., Wolf, U., Tommerup, N., Schempp, W., and Scherer, G. (1994) Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 1111-1112
23. Wright, E., Hargrave, M. R., Christiansen, J., Cooper, L., Kun, J., Evans, T., Gangadharan, U., Greenfield, A., and Koopman, P. (1995) The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nature Genet. 9, 15-20
24. Scherer, S. W., Poorkaj, P., Allen, T., Kim, J., Geshuri, D., Nunes, M., Soder, S., Stephens, K., Pagon, R. A., Patton, M. A., Berg, M. A., Donlon, T., Rivera, H., Pfeiffer, R. A., Naritomi, K., Hughes, H., Genuardi, M., Gurrieri, F., Neri, G., Lovrein, E., Magenis, E., Tsui, L.-C., and Evans, J. P. (1994) Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1. Am. J. Human Genet. 55, 12-20
25. Nunes, M. E., Schutt, G., Kapur, R. P., Luthardt, F., Kukolich, M., Byers, P., and Evans, J. P. (1995) A second autosomal split hand/split foot locus maps to chromosome 10q24-q25. Human Mol. Genet. 4, 2165-2170
26. Johnson, K. R., Lanc, P. W., Ward-Bailey, P., and Davisson, M. T. (1995) Mapping the mouse dactylaplasia mutation, Dac, and a gene that controls its expression, mdac. Genomics 29, 457-464
27. Mundlos, S., Mulliken, J. B., Abramson, D. L., Warman, M. L., Knoll, J. H., and Olsen, B. R. (1995) Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family. Human Mol. Genet. 4, 71-75
28. Sillence, D. O., Ritrhie, H. E., and Selby, P. B. (1987) Animal model: skeletal anomalies in mice with cleidocranial dysplasia. Am. J. Med. Genet. 27, 75-85
29. Basson, C. T., Cowley, G. S., Solomon, S. D., Weissman, B., Poznanski, A. K., Traill, T. A., Seidman J. G., and Seidman C. E. (1994) The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). New Engl. J Med. 330, 885-891
30. Ohlsson, C., Nilsson, A., Isaksson, O., and Lindahl, A. (1992) Growth hormone induces multiplication of the slowly cycling germinal cells of the rat tibial growth plate. Proc. Natl. Acad. Sci. USA 89, 9826-9830
31. Baker, J., Liu, J. P., Robertson, E. J., and Efstratiadis, A. (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 73-82
32. Wajnrajch, M. P., Gertner, J. M., Harbison, M. D., Chua, S. C., Jr., and Leibel, R. L. (1996) Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nature Genet. 12, 88-89
33. Godfrey, P., Rahal, J. O., Beamer, W. G., Copeland, N. G., Jenkins, N. A., and Mayo, K. E. (1993) GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nature Genet. 4, 227-232
34. Liu, J.-P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor (Igf-1) and type I IGF receptor (Igf1r). Cell 75, 59-72
35. Givol, D., and Yayon, A. (1992) Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 6, 3362-3369.
36. Shiang, R., Thompson, L. M., Zhu, V. Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T., and Wasmuth, J. J. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78, 335-342
37. Superti-Furga, A., Eich, G., Bucher, H. U., Wisser, J., Giedion, A., Gitzelmann, R., and Steinmann, B. (1995) A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in newborns with achondroplasia. Eur. J. Ped. 154, 215-219
38. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P. (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911-921
39. Naski, M. C., Wang, Q., Xu, J., and Ornitz, D. M. (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet. 13, 233-237
40. Bonaventure, J., Rousseau, F., Legeai-Mallet, L., Merrer, M. L., Munnich, A., and Maroteaux, P. (1996) Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Am. J. Med. Genet. 63, 148-154
41. McKusick, V. A., Kelly, T. E., and Dorst, J. P. (1973) Observations suggesting allelism of the achondroplasia and hypochondroplasia genes. J. Med. Genet. 10, 11-16
42. Bellus, G. A., McIntosh, I., Smith, E. A., Aylsworth, A. S., Kaitila, I., Horton, W. A., Greenhaw, G. A., Hecht, J. T., and Francomano, C. A. (1995) A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nature Genet. 10, 357-359
43. Stoilov, I., Kilpatrick, M. W., and Tsipouras, P. (1995) Possible genetic heterogeneity in hypochondroplasia. J. Med. Genet. 45, 492-493
44. Stanescu, R., Stanescu, V., and Moroteaux, P. (1990) Homozygous achondroplasia: morphologic and biochemical study of cartilage. Am. J. Med. Genet. 27, 412-421
45. Rousseau, F., Saugier, P., Le Merrer, M., Munnich, A., Delezoide, A. L., Maroteaux, P., Bonaventure, J., Narcy, F., and Sanak, M. (1995) Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nature Genet. 10, 11-12
46. Tavormina, P. L., Shiang, R., Thompson, L. M., Zhu, Y. Z., Wilkin, D. J., Lachman, R. S., Wilcox, W. R., Rimoin, D. L., Cohn, D. H., and Wasmuth, J. J. (1995) Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet. 9, 321-328
47. Meyers, G. A., Orlow, S. J., Munro, I. R., Przylepa, K. A., and Jabs, E. W. (1995) Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nature Genet. 11, 462-463
48. Philbrick, W. M., Wysolmerski, J. J., Galbraith, S., Holt, E., Orloff, J. J., Yang, K. H., Vasavada, R. C., Weir, E. C., Broadus, A. E., and Stewart, A. F. (1996) Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol. Rev. 76, 127-173
49. Lee, K., Deeds, J. D., and Segre, G. V. (1995) Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology 136, 453-463
50. Lee, K., Deeds, J. D., Bond, A. T., Juppner, H., Abou-Samra, A. B., and Segre, G. V. (1993) In situ localization of PTH/PTHrP receptor mRNA in the bone of fetal and young rats. Bone 14, 341-345
51. Karaplis, A. C., Luz, A., Glowacki, J., Roderick, T. B., Tybelewicz, V. L. J., Kronenberg, H. M., and Mulligan, R. C. (1994) Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes & Dev. 8, 277-289
52. Schipani, E., Kruse, K., and Juppner, H. (1995) A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268, 98-100
53. Reardon, W., Winter, R. M., Rutland, P., Pulleyn, L. J., Jones, B. M., and Malcolm, S. (1994) Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet. 8, 98-103
54. Muenke, M., Schell, U., Hahr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., and Winter, R. M. (1994) A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet. 8, 269-274
55. Jabs, E. W., Li, X., Scott, A. F., Meyers, G., Chen, W., Eccles, M., Mao, J., Charnas, L. R., Jackson, C. E., and Jaye, M. (1994) Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nature Genet. 8, 275-279
56. Rutland, P., Pulleyn, L. J., Reardon, W., Baraitser, M., Hayward, R., Jones, B., Malcolm, S., Winter, R. M., Oldridge, M., Slaney, S. F., Poole, M. D., and Wilkie, O. M. (1995) Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nature Genet. 9, 173-176
57. Fallon, J. F., Lopez, A., Ros, M. A., Savage, M. P., Olwin, B. B., and Simandl, B. K. (1994) FGF-2: apical ectodermal ridge growth signal for chick limb development. Science 264, 104-107
58. Niswander, L., and Martin, G. R. (1992) Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development 114, 755-768
59. Crossley, P. H., and Martin, G. R. (1995) The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121, 439-451
60. Peters, K. G., Werner, S. and Williams, L. T. (1993) Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114, 232-243